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Article - Autopsy Case Report
ABSTRACT
Ameloblastoma is an uncommon and locally aggressive, benign, odontogenic tumor, with local recurrence when not 
adequately excised. A rare variant of this neoplasm with the benign features but accompanied with metastases has been 
described. This rare variant is malignant ameloblastoma and is known to have a poor prognosis. We present the case 
of a young woman who had recurrent mandibular tumors, which were resected twice and histologically reported as 
ameloblastoma. Four years later, she presented with pulmonary metastasis and atelectasis. A review of the literature on 
this very rare neoplasm was also performed. 
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CASE REPORT
A 25-year-old female presented to the hospital 
with a 6-month history of exertional dyspnea and 
unproductive cough. She denied hemoptysis, chest 
pain, or orthopnea. Her past medical history included 
a painless mandibular mass removed through a 
conservative surgical procedure, in another hospital 
facility, 5 years before. This relapsed 2 years later and 
required a re-excision at the same facility. She was told 
that the excised tissue was reported as ameloblastoma, 
but did not retain a copy of the histological report. 
A month before presenting at our facility, she had a 
mandibular reconstruction of the second excision’s 
surgical site.
On physical examination, she was mildly tachypneic 
with the respiratory rate of 22 breaths/min. There was 
a dull percussion on the entire left hemithorax where 
no breath sounds were audible. She had a swelling 
on the right lower jaw measuring 3 cm in diameter 
with an overlying surgical scar. The remaining physical 
examination was unremarkable.
The chest x-ray showed a homogenous opacity on 
the left hemithorax with ipsilateral tracheal deviation 
and mediastinal shift. A computerized tomography 
scan showed a left posteromedial soft tissue mass 
with the upper pulmonary lobe atelectasis. A working 
diagnosis of a mediastinal tumor — probably of 
thymic origin — was considered, and the patient 
was subjected to a left thoracotomy. Intraoperatively, 
the mass was occupying the space between the 
descending thoracic aorta and the pericardium with 
partial left lung collapse. Efforts to remove the tumor 
provoked profuse and uncontrollable bleeding; the 
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patient developed hemorrhagic shock followed by 
cardiopulmonary arrest, resulting in death.
Permission for a limited autopsy of the thorax to 
obtain biopsy samples of the tumor was obtained from 
the patient’s relatives. The autopsy showed an oval to 
globular mass in the mediastinum firmly adhered to 
the pericardium and the mediastinal surface of the left 
lung (Figure 1A and 1B).
The tumor was firm in consistency, measured 
12 × 9 × 8 cm, and weighed 140 g. At the cut surface, 
the mass showed a greyish and whitish lobulated 
appearance with areas of anthracotic pigment 
deposits, and a greenish fluid was draining from its 
surface. There were multiple nodules on the pleural 
surface of the left lung. Cut sections of the lung 
showed consolidations, with extension of the tumor 
into the lumen of the left bronchus.
Histology of the tumor showed nodular aggregates 
of stellate and spindle-shaped cells arranged in a 
reticular appearance, which were bounded by low 
columnar cells arranged in a palisade (Figure 2A). These 
cells have a coarse chromatin nuclear pattern and 
moderate amphophilic cytoplasm (Figure 2B and 2C). 
There were very few mitotic figures in the tumor cells 
(Figure 2B and 2C).
There was infiltration of the trachea by the tumor 
cells (Figure 3). Focal nests of tumor cells within 
the lung were also seen (Figure 3D). A diagnosis of 
metastatic ameloblastoma was made.
DISCUSSION
Ameloblastoma is a rare, benign, aggressive 
neoplasm of the odontogenic tissue with a global 
incidence of 0.5 cases per million person years.1 It is 
said to be five times more common in blacks compared 
to whites.1,2 Studies undertaken in Ibadan (Nigeria) 
have shown that the ameloblastoma is the third 
commonest tumor of the jaw, with a frequency of 
1%–3%.3 Most studies report a slight male predilection 
1.1–1.3:1 with the mean presentation age of 32 years 
(range 2–80 years).3,4 The tumor has a low recurrence 
rate if adequate excision margins are respected, with 
subsequent jaw reconstruction. Conservative surgery 
has a high recurrence rate as was seen in our patient.1
Malignant ameloblastoma is a rare odontogenic 
tumor accounting for about 2% of the ameloblastic 
tumors.1 The term “malignant ameloblastoma” 
describes a tumor having benign histological features 
but showing evidence of metastasis.1,5 The commonest 
site of occurrence is the mandible, followed by the 
maxilla, with a patient age range of 5 to 74 years.5 
These features were seen in our patient who presented 
Figure 1. Gross view of the neoplasm. A – The tumor (T) attached to the left lung (L) and the parietal pericardium 
(P); B – The cut surface of the tumor shows a greyish-white mass attached to the lung surface.
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the primary tumor at the age of 20 years, and the 
metastases occurred at the age of 25 years.
There is no sex predominance, and metastasis 
to the lungs is commonly followed by regional 
lymph nodes, bones, liver, brain, and spinal cord.1,2,6 
Metastasis to the mediastinum, as seen in our index 
case, is very rare. Malignant ameloblastomas appear to 
have an indolent yet persistent behavior with multiple 
recurrences, as seen in our patient.6 The average time 
interval between the diagnosis of ameloblastoma and 
the detection of metastasis ranges from 3 to 45 years 
with a mean of 18 years.6 The index patient had a 5-year 
interval between the primary tumor and the metastasis. 
There are very few reported cases of mediastinal 
involvement by malignant ameloblastoma. The tumors 
in two previously reported cases had biopsies since the 
tumors were unresectable.7,8 This was due to extensive 
lymph node involvement, which was similar to that 
seen in our patient. The metastatic tumors in these two 
reported cases were described as having the typical 
nest of odontogenic cells arranged in a loose reticulum 
network.7,8 The prognosis of malignant ameloblastoma 
has been described as poor with a median survival time 
of 2 years if no resection is done.8 The survival increases 
to 6 years with adequate resection and radiotherapy.8
Recent molecular characterization of the tumor 
has shown frequent mutations in the BRAF, MAPK, and 
FGFR2 genetic pathways in ameloblastomas.9 Each of 
these mutations were found to be mutually exclusive 
in most of the tumors. The BRAFV600E, a mutation 
seen in many different other tumors, such as melanoma 
and glioblastoma, was the commonest mutation seen 
Figure 2. Photomicrography of the tumor. A – Nests and trabeculae of malignant cells show peripheral palisading 
of darkly staining cells with loose cells in the center (H&E, 250X); B and C – High power view showing stellate cells 
having a reticular appearance, and palisading columnar to polygonal cells at the periphery (H&E, 400X).
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Figure 3. Photomicrography of the tumor. A, B and C – Infiltration of the trachea and bronchi by the malignant 
cells (H&E, 250X); D – A nest of tumor cells within the lung parenchyma (H&E, 250X).
occurring in about 64% of ameloblastomas.9 Clinical 
trials of inhibitors of these pathways are currently 
ongoing and are showing promising results, which 
may help in better patient management.9
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